Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Wave Life Sciences Ltd.

Announce data from the Phase 1b/2a PRECISION-HD1 and PRECISION-HD2 trials

Delivered by the deadline

AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.

Announced
4 Mar 2021
Due
31 Mar 2021
Delivered
29 Mar 2021
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“We remain on track to announce data from the Phase 1b/2a PRECISION-HD1 and PRECISION-HD2 trials at the end of the first quarter of 2021”

What we found

Evidence strength A What the grades mean

A later 10-Q says the company announced PRECISION-HD2 results on March 29, 2021, before the end-of-Q1 deadline, in announcing its decision to discontinue the first-generation programs.

  • A
    Wave Life Sciences Ltd. 8-K filed 2021-05-13 Regulatory filing · published 13 May 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “Despite our PRECISION-HD results at the end of the first quarter” ✓ confirmed on the page
  • A
    Wave Life Sciences Ltd. 10-Q filed 2021-05-13 Regulatory filing · published 13 May 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “On March 29, 2021, we announced our decision to discontinue clinical development of WVE-120102 and WVE-120101, our first-generation programs, for patients with Huntington’s disease.” ✓ confirmed on the page
  • A
    Wave Life Sciences Ltd. 10-Q filed 2021-05-13 Regulatory filing · published 13 May 2021 · retrieved 27 Oct 2026 · kept permanently by the SEC
    “The decision to discontinue WVE-120102 was based on the results of the 15 PRECISION-HD2 clinical trials” ✓ confirmed on the page

Checked 27 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Announce
Deliverable
Data from PRECISION-HD1 and PRECISION-HD2 Phase 1b/2a trials
Language
Firm (“will”, “on track to”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.

Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works

Are you Wave Life Sciences Ltd.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-WVE-025137 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.